TIMOTHY KELLY: Open Payments
NPI 1164193751 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,260 in 226 payments from 19 companies in 2025. Trend: 2023 $2,245 · 2024 $3,345 · 2025 $4,260
Food & beverage: $3,629Consulting: $375Education: $256
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $740 |
| LEO Pharma Inc. | 8 | $505 |
| Galderma Laboratories, L.P. | 38 | $434 |
| Janssen Biotech, Inc. | 18 | $385 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $244 |
| Regeneron Healthcare Solutions, Inc. | 11 | $238 |
| UCB, Inc. | 15 | $233 |
| Lilly USA, LLC | 10 | $232 |
| Arcutis Biotherapeutics, Inc. | 18 | $232 |
| Amgen Inc. | 12 | $219 |
Products named: ADBRY, RINVOQ, NEMLUVIO, TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, Zoryve.
Industry payments across NJ — which companies pay providers there.
